Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

H+ Transporting Two Sector ATPase Pipeline Report 2016: Therapeutics Review of 2 Companies & 6 Molecules - Research and Markets

Research and Markets
Posted on: 11 Oct 16

Research and Markets has announced the addition of the "H+ Transporting Two Sector ATPase (F1F0 ATP Synthase or ATP Synthase or Mitochondrial ATPase or Bacterial Ca2+/Mg2+ ATPase or EC 3.6.3.14) - Pipeline Review, H2 2016" report to their offering.

H+ Transporting Two Sector ATPase is an important enzyme that creates the energy storage molecule adenosine triphosphate (ATP). The majority of cellular energy in the form of adenosine triphosphate (ATP) is synthesized by the ubiquitous F1F0 ATP synthase. Power for ATP synthesis derives from an electrochemical proton (or Na+) gradient, which drives rotation of membranous F0 motor components.

H+ Transporting Two Sector ATPase pipeline Target constitutes close to 6 molecules. Out of which approximately 5 molecules are developed by Companies and remaining by the Universities/Institutes. The molecules developed by Companies in Pre-Registration, Phase II, Preclinical and Discovery stages are 1, 1, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecule, respectively.

H+ Transporting Two Sector ATPase - Pipeline Review, H2 2016, outlays comprehensive information on the H+ Transporting Two Sector ATPase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in H+ Transporting Two Sector ATPase targeted therapeutics development, features dormant and discontinued projects and latest news and press releases.

Key Topics Covered:

  1. Introduction
  2. H+ Transporting Two Sector ATPase Overview
  3. Therapeutics Development
  4. Pipeline Products for H+ Transporting Two Sector ATPase - Overview
  5. Pipeline Products for H+ Transporting Two Sector ATPase - Comparative Analysis
  6. H+ Transporting Two Sector ATPase - Therapeutics under Development by Companies
  7. H+ Transporting Two Sector ATPase - Therapeutics under Investigation by Universities/Institutes
  8. H+ Transporting Two Sector ATPase Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. H+ Transporting Two Sector ATPase - Products under Development by Companies
  13. H+ Transporting Two Sector ATPase - Products under Investigation by Universities/Institutes
  14. H+ Transporting Two Sector ATPase - Companies Involved in Therapeutics Development
  • Johnson & Johnson
  • Lycera Corp.

For more information about this report visit http://www.researchandmarkets.com/research/6grrs2/h_transporting

View source version on businesswire.com: http://www.businesswire.com/news/home/20161011005826/en/

Business Wire
www.businesswire.com

Last updated on: 11/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.